Inogen Inc (INGN) stock
INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3068% below fair value
$5.68+0.05 (+0.98%)
Close on Nov 17, 2026Market cap $150.87MP/E –Yield –
Inogen total assets
Total assets on the balance sheet at the end of each period.
Inogen's total assets was $285.57M at Jun 30, 2026. For fiscal 2025 it was $298.63M, up 0.8% from the year before. Over ten years it grew 6.4% a year on average. The highest annual figure on record is $489.51M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $298.63M | +0.8% |
| FY2024 | Dec 31, 2024 | $296.19M | -9.2% |
| FY2023 | Dec 31, 2023 | $326.19M | -19.5% |
| FY2022 | Dec 31, 2022 | $405.04M | -17.3% |
| FY2021 | Dec 31, 2021 | $489.51M | +6.0% |
| FY2020 | Dec 31, 2020 | $461.85M | +3.2% |
| FY2019 | Dec 31, 2019 | $447.34M | +19.0% |
| FY2018 | Dec 31, 2018 | $375.90M | +36.7% |
| FY2017 | Dec 31, 2017 | $275.07M | +28.5% |
| FY2016 | Dec 31, 2016 | $214.05M | +32.7% |
| FY2015 | Dec 31, 2015 | $161.31M | +15.2% |
| FY2014 | Dec 31, 2014 | $140.09M | +70.0% |
| FY2013 | Dec 31, 2013 | $82.40M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $285.57M | -8.5% |
| Q1 FY2026 | Mar 31, 2026 | $285.93M | -7.3% |
| Q4 FY2025 | Dec 31, 2025 | $298.63M | +0.8% |
| Q3 FY2025 | Sep 30, 2025 | $307.01M | +0.3% |
| Q2 FY2025 | Jun 30, 2025 | $312.04M | +1.0% |
| Q1 FY2025 | Mar 31, 2025 | $308.41M | -2.3% |
| Q4 FY2024 | Dec 31, 2024 | $296.19M | -9.2% |
| Q3 FY2024 | Sep 30, 2024 | $306.17M | -10.9% |
| Q2 FY2024 | Jun 30, 2024 | $308.92M | -17.5% |
| Q1 FY2024 | Mar 31, 2024 | $315.60M | -18.2% |
| Q4 FY2023 | Dec 31, 2023 | $326.19M | -19.5% |
| Q3 FY2023 | Sep 30, 2023 | $343.70M | -26.8% |
| Q2 FY2023 | Jun 30, 2023 | $374.35M | -20.4% |
| Q1 FY2023 | Mar 31, 2023 | $385.67M | -18.7% |
| Q4 FY2022 | Dec 31, 2022 | $405.04M | -17.3% |
| Q3 FY2022 | Sep 30, 2022 | $469.58M | -8.4% |
| Q2 FY2022 | Jun 30, 2022 | $470.07M | -5.6% |
| Q1 FY2022 | Mar 31, 2022 | $474.62M | -0.4% |
| Q4 FY2021 | Dec 31, 2021 | $489.51M | +6.0% |
| Q3 FY2021 | Sep 30, 2021 | $512.86M | +11.4% |
| Q2 FY2021 | Jun 30, 2021 | $498.17M | +8.7% |
| Q1 FY2021 | Mar 31, 2021 | $476.48M | +3.8% |
| Q4 FY2020 | Dec 31, 2020 | $461.85M | +3.2% |
| Q3 FY2020 | Sep 30, 2020 | $460.33M | +3.5% |
| Q2 FY2020 | Jun 30, 2020 | $458.12M | +13.5% |
| Q1 FY2020 | Mar 31, 2020 | $459.12M | +18.3% |
| Q4 FY2019 | Dec 31, 2019 | $447.34M | +19.0% |
| Q3 FY2019 | Sep 30, 2019 | $444.73M | +24.5% |
| Q2 FY2019 | Jun 30, 2019 | $403.77M | +21.4% |
| Q1 FY2019 | Mar 31, 2019 | $388.20M | +29.4% |
| Q4 FY2018 | Dec 31, 2018 | $375.90M | +36.7% |
| Q3 FY2018 | Sep 30, 2018 | $357.11M | +32.3% |
| Q2 FY2018 | Jun 30, 2018 | $332.64M | +32.4% |
| Q1 FY2018 | Mar 31, 2018 | $299.88M | +31.7% |
| Q4 FY2017 | Dec 31, 2017 | $275.07M | +28.5% |
| Q3 FY2017 | Sep 30, 2017 | $269.84M | +27.7% |
| Q2 FY2017 | Jun 30, 2017 | $251.23M | – |
| Q1 FY2017 | Mar 31, 2017 | $227.63M | – |
| Q4 FY2016 | Dec 31, 2016 | $214.05M | – |
| Q3 FY2016 | Sep 30, 2016 | $211.31M | – |
See a number that looks wrong?